Locoid Lipid Krem 1 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

locoid lipid krem 1 mg/g

cheplapharm arzneimittel gmbh - hydrocortisonum bútýrat - krem - 1 mg/g

Locoid Crelo Húðfleyti 0,1 % Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

locoid crelo húðfleyti 0,1 %

cheplapharm arzneimittel gmbh - hydrocortisonum bútýrat - húðfleyti - 0,1 %

Locoid Smyrsli 1 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

locoid smyrsli 1 mg/g

cheplapharm arzneimittel gmbh - hydrocortisonum bútýrat - smyrsli - 1 mg/g

Locoid Húðlausn 1 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

locoid húðlausn 1 mg/ml

cheplapharm arzneimittel gmbh - hydrocortisonum bútýrat - húðlausn - 1 mg/ml

Locoid Krem 1 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

locoid krem 1 mg/g

cheplapharm arzneimittel gmbh - hydrocortisonum bútýrat - krem - 1 mg/g

Protopic Evrópusambandið - íslenska - EMA (European Medicines Agency)

protopic

leo pharma a/s - takrólímus - dermatitis, atópísk - aðrar húðsjúkdómar - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. koma fjórir eða meira sinnum á ári) sem hafa haft fyrstu viðbrögð við sex vikur meðferð tvisvar á dag takrólímus smyrslið (sár ruddi, næstum ruddi eða dálítið áhrifum).